Key result
Anterior-circulation stroke independently predicted hemorrhagic infarction type 1 and type 2 in alteplase-treated acute ischemic stroke patients.
Why the study?
Most studies evaluated post-alteplase haemorrhagic transformation as a homogeneous entity rather than assessing predictors for each subtype.
Cohort (n=616)
Yes
Higher NIHSS, cardioembolic stroke, and atrial fibrillation are independent predictors of all subtypes of hemorrhagic transformation following alteplase treatment for acute ischemic stroke.
Answers are grounded in this paper and cite their sources.
Subtype-specific predictors of post-alteplase haemorrhagic transformation warrant consideration; leaves open whether they refine risk stratification in AIS.
Worldwide, stroke is a leading cause of long-term disability in adults. Alteplase is the only approved treatment for acute ischemic stroke (AIS) and results in an improvement in a third of treated patients. Most studies evaluated the post-alteplase haemorrhagic transformation of brain infarction as a homogeneous entity but we evaluated the predictors of each subtype of haemorrhagic transformation of brain infarction. Our trial included 616 AIS alteplase-treated patients. We evaluated the ability of different risk factors, clinical presentation, and imaging features to predict different haemorrhagic transformation (HT) subtypes. HT was seen in 152 patients (24.7%), higher NIHSS, cardioembolic stroke and atrial fibrillation were independent predictors of all ECASS-based subtypes of hemorrhagic infarction, in addition, anterior-circulation stroke was an independent predictor of hemorrhagic infarction type 1 (odds ratio [OR], 11.04; 95% CI, 9.81 to 12.70; P-value > 0.001) and type2 (OR, 11.89; 95% CI, 9.79 to 14.44; P-value > 0.001), while older age was also an independent predictor of parenchymal hematoma type1 (OR, 1.312; 95% CI, 1.245 to 1.912; P-value 0.02). In AIS patients treated with alteplase in Egypt and Saudi Arabia, higher NIHSS, cardioembolic stroke and atrial fibrillation were independent predictors of all ECASS-based subtypes of hemorrhagic infarction; in addition, anterior-circulation stroke was an independent predictor of hemorrhagic infarction type 1 and 2, while older age was also an independent predictor of parenchymal hematoma type1. Trial registration: (clinicaltrials.gov NCT06337175), retrospectively registered on 29/03/2024.
No takes yet. Share an insight, caveat, or question.
Zeinhom et al. (2024) conducted a cohort in Acute ischemic stroke (n=616). Anterior-circulation stroke and other clinical risk factors was evaluated on Hemorrhagic infarction type 1 (OR 11.04, 95% CI 9.81 to 12.70, p=> 0.001). Anterior-circulation stroke independently predicted hemorrhagic infarction type 1 and type 2 in alteplase-treated acute ischemic stroke patients.
Synapse has enriched 10 related papers. Consider them for comparative context: